Published in PLoS One on October 21, 2013
An activin receptor IIA ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin. Br J Haematol (2014) 0.87
The soluble form of BMPRIB is a novel therapeutic candidate for treating bone related disorders. Sci Rep (2016) 0.75
Activin A more prominently regulates muscle mass in primates than does GDF8. Nat Commun (2017) 0.75
Identification of the haematopoietic stem cell niche and control of the niche size. Nature (2003) 18.17
TGF-beta signal transduction. Annu Rev Biochem (1998) 17.83
Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature (1997) 14.82
Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol (2005) 11.18
BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat Genet (2004) 7.37
Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet (2000) 7.20
Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A (2001) 6.38
Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet (1996) 5.15
Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science (2005) 4.58
Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet (2009) 4.49
Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development (1996) 3.91
Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood (2006) 3.59
Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc Natl Acad Sci U S A (2005) 3.52
Tgf-beta superfamily signaling in embryonic development and homeostasis. Dev Cell (2009) 3.51
Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev (2002) 3.06
An essential role of Bmp4 in the atrioventricular septation of the mouse heart. Genes Dev (2003) 2.95
BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci (2007) 2.95
Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol Cell Biol (2003) 2.90
Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo. Proc Natl Acad Sci U S A (2005) 2.82
The bone morphogenetic protein system in mammalian reproduction. Endocr Rev (2004) 2.64
BMP10 is essential for maintaining cardiac growth during murine cardiogenesis. Development (2004) 2.50
The Ig(kappa) enhancer influences the ratio of Ig(kappa) versus Ig(lambda) B lymphocytes. Immunity (1996) 2.39
Consequences of knocking out BMP signaling in the mouse. Genesis (2003) 2.36
Bone morphogenetic protein-3 is a negative regulator of bone density. Nat Genet (2001) 2.34
Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension. Hum Mutat (2006) 2.30
The transforming growth factor-beta superfamily of receptors. Cytokine Growth Factor Rev (2004) 2.15
Bone morphogenetic protein signaling is essential for terminal differentiation of the intestinal secretory cell lineage. Gastroenterology (2007) 2.07
Crystal structure of BMP-9 and functional interactions with pro-region and receptors. J Biol Chem (2005) 2.03
Tgf-Beta signaling in development. Sci STKE (2007) 1.70
Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators. Mol Endocrinol (2008) 1.59
Promiscuity and specificity in BMP receptor activation. FEBS Lett (2012) 1.58
BMP signaling in vascular diseases. FEBS Lett (2012) 1.51
Dosage-dependent requirement of BMP type II receptor for maintenance of vascular integrity. Blood (2007) 1.39
A low expressor line of transgenic mice carrying a mutant human Cu,Zn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis. Acta Neuropathol (1997) 1.39
Distinct developmental programs require different levels of Bmp signaling during mouse retinal development. Development (2005) 1.33
Bone morphogenetic protein receptor II regulates pulmonary artery endothelial cell barrier function. Blood (2010) 1.31
Identification of receptors and signaling pathways for orphan bone morphogenetic protein/growth differentiation factor ligands based on genomic analyses. J Biol Chem (2005) 1.28
BMP signaling in vascular development and disease. Cytokine Growth Factor Rev (2010) 1.26
Double trans-chromosomic mice: maintenance of two individual human chromosome fragments containing Ig heavy and kappa loci and expression of fully human antibodies. Proc Natl Acad Sci U S A (2000) 1.22
Mutation of an upstream cleavage site in the BMP4 prodomain leads to tissue-specific loss of activity. Development (2006) 1.18
Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivo. J Bone Miner Res (2010) 1.18
Characterization of the ligand binding functionality of the extracellular domain of activin receptor type IIb. J Biol Chem (2010) 1.16
Erythropoietin stimulates spleen BMP4-dependent stress erythropoiesis and partially corrects anemia in a mouse model of generalized inflammation. Blood (2010) 1.13
An in vivo reporter of BMP signaling in organogenesis reveals targets in the developing kidney. BMC Dev Biol (2008) 1.12
Receptor oligomerization and beyond: a case study in bone morphogenetic proteins. BMC Biol (2009) 1.12
New roles and mechanism of action of BMP4 in postnatal tooth cytodifferentiation. Bone (2010) 1.04
Deletion of BMP7 affects the development of bones, teeth, and other ectodermal appendages of the orofacial complex. J Exp Zool B Mol Dev Evol (2009) 1.02
Extramedullary erythropoiesis in the adult liver requires BMP-4/Smad5-dependent signaling. Exp Hematol (2009) 1.02
A soluble activin receptor type IIb prevents the effects of androgen deprivation on body composition and bone health. Endocrinology (2010) 1.01
Activin receptor antagonists for cancer-related anemia and bone disease. Expert Opin Investig Drugs (2012) 0.99
Constitutively active ALK2 receptor mutants require type II receptor cooperation. Mol Cell Biol (2013) 0.96
Sotatercept, a soluble activin receptor type 2A IgG-Fc fusion protein for the treatment of anemia and bone loss. Curr Opin Mol Ther (2010) 0.94
Mutation in Bmp7 exacerbates the phenotype of Bmp8a mutants in spermatogenesis and epididymis. Dev Biol (2001) 0.93
Bmp indicator mice reveal dynamic regulation of transcriptional response. PLoS One (2012) 0.85
A novel transgenic chimaeric mouse system for the rapid functional evaluation of genes encoding secreted proteins. Nucleic Acids Res (2005) 0.78
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest (2004) 7.00
Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science (2005) 4.58
An acidic matrix protein, Pif, is a key macromolecule for nacre formation. Science (2009) 3.38
Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proc Natl Acad Sci U S A (2005) 3.24
R-Spondin proteins: a novel link to beta-catenin activation. Cell Cycle (2006) 2.56
Sequential targeting of the genes encoding immunoglobulin-mu and prion protein in cattle. Nat Genet (2004) 2.22
Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther (2012) 2.15
Cloned transchromosomic calves producing human immunoglobulin. Nat Biotechnol (2002) 2.13
Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism. Am J Physiol Renal Physiol (2005) 2.05
Sentinel node mapping guided by indocyanine green fluorescence imaging in gastric cancer. Ann Surg (2009) 2.04
IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells (2008) 1.75
R-spondin1 plays an essential role in ovarian development through positively regulating Wnt-4 signaling. Hum Mol Genet (2008) 1.69
Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J Gastroenterol Hepatol (2008) 1.68
Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Nucleic Acids Res (2004) 1.67
Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling. Mol Cell Biol (2003) 1.63
miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer. Cancer Sci (2011) 1.57
MOZ is essential for maintenance of hematopoietic stem cells. Genes Dev (2006) 1.56
Stacking of conical molecules with a fullerene apex into polar columns in crystals and liquid crystals. Nature (2002) 1.42
Metal-intercalated aromatic hydrocarbons: a new class of carbon-based superconductors. Phys Chem Chem Phys (2011) 1.37
MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. Biomarkers (2009) 1.35
In vivo analysis of insertional torque during pedicle screwing using cortical bone trajectory technique. Spine (Phila Pa 1976) (2014) 1.33
Negative regulation of platelet clearance and of the macrophage phagocytic response by the transmembrane glycoprotein SHPS-1. J Biol Chem (2002) 1.30
The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells. J Exp Med (2011) 1.29
A novel KCNQ4 one-base deletion in a large pedigree with hearing loss: implication for the genotype-phenotype correlation. J Hum Genet (2006) 1.24
An adult case of Bochdalek hernia complicated with hemothorax. Respiration (2004) 1.23
Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int J Radiat Oncol Biol Phys (2002) 1.23
Evolutional study on acetylcholine expression. Life Sci (2003) 1.22
Mechanically induced luminescence changes in molecular assemblies. Nat Chem (2009) 1.16
Intraoperative fluorescent imaging using indocyanine green for liver mapping and cholangiography. J Hepatobiliary Pancreat Sci (2009) 1.15
Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques. J Nucl Med (2006) 1.13
Glomangiopericytoma of the nasal cavity. Auris Nasus Larynx (2010) 1.10
A randomized controlled trial of multicomponent exercise in older adults with mild cognitive impairment. PLoS One (2013) 1.10
A case of paranasal sinus lesions in IgG4-related sclerosing disease. Otolaryngol Head Neck Surg (2009) 1.08
A new melanoma antigen fatty acid-binding protein 7, involved in proliferation and invasion, is a potential target for immunotherapy and molecular target therapy. Cancer Res (2006) 1.08
Functional redundancy of the Notch gene family during mouse embryogenesis: analysis of Notch gene expression in Notch3-deficient mice. Biochem Biophys Res Commun (2005) 1.08
Sentinel node mapping guided by indocyanine green fluorescence imaging during laparoscopic surgery in gastric cancer. Ann Surg Oncol (2010) 1.08
Asymptomatic microbleeds in moyamoya disease: T2*-weighted gradient-echo magnetic resonance imaging study. J Neurosurg (2005) 1.07
Cortical hypometabolism and hypoperfusion in Parkinson's disease is extensive: probably even at early disease stages. Brain Struct Funct (2010) 1.07
Comparative marker analysis of extracellular vesicles in different human cancer types. J Extracell Vesicles (2013) 1.06
Association of NKT cells and granulocytes with liver injury after reperfusion of the portal vein. Cell Immunol (2005) 1.05
An integrative genomic analysis revealed the relevance of microRNA and gene expression for drug-resistance in human breast cancer cells. Mol Cancer (2011) 1.05
Craniofacial malformation in R-spondin2 knockout mice. Biochem Biophys Res Commun (2009) 1.05
Cortical bone trajectory for lumbosacral fixation: penetrating S-1 endplate screw technique: technical note. J Neurosurg Spine (2014) 1.03
Production of human monoclonal and polyclonal antibodies in TransChromo animals. Cloning Stem Cells (2002) 1.03
CrkL directs ASAP1 to peripheral focal adhesions. J Biol Chem (2003) 1.02
Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragment. Proc Natl Acad Sci U S A (2004) 1.00
Trans-chromosomic mice containing a human CYP3A cluster for prediction of xenobiotic metabolism in humans. Hum Mol Genet (2012) 1.00
Micromanaging Iron Homeostasis: hypoxia-inducible micro-RNA-210 suppresses iron homeostasis-related proteins. J Biol Chem (2012) 0.98
CT-guided transthoracic needle biopsy using a puncture site-down positioning technique. AJR Am J Roentgenol (2006) 0.98
Late-onset hearing loss in a mouse model of DFN3 non-syndromic deafness: morphologic and immunohistochemical analyses. Hear Res (2002) 0.97
Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study. Brain (2002) 0.96
Identification of erythropoietin-induced microRNAs in haematopoietic cells during erythroid differentiation. Br J Haematol (2008) 0.96
Early experience with 3-T magnetic resonance tractography in the surgery of cerebral arteriovenous malformations in and around the visual pathway. Neurosurgery (2006) 0.96
New treatment for invasive fungal sinusitis: three cases of chronic invasive fungal sinusitis treated with surgery and voriconazole. Auris Nasus Larynx (2009) 0.95
Gray matter-white matter contrast on spin-echo T1-weighted images at 3 T and 1.5 T: a quantitative comparison study. Eur Radiol (2007) 0.94
Self-organization of oriented calcium carbonate/polymer composites: effects of a matrix peptide isolated from the exoskeleton of a crayfish. Angew Chem Int Ed Engl (2006) 0.94
Microbleeds in moyamoya disease: susceptibility-weighted imaging versus T2*-weighted imaging at 3 Tesla. Invest Radiol (2008) 0.94
One-dimensional ion transport in self-organized columnar ionic liquids. J Am Chem Soc (2004) 0.94
A case of myoepithelioma of the nasal cavity. Auris Nasus Larynx (2010) 0.94
Comparison of 3.0- and 1.5-T three-dimensional time-of-flight MR angiography in moyamoya disease: preliminary experience. Radiology (2006) 0.94
Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies. Acta Neuropathol (2002) 0.93
Injured corneal epithelial cells promote myodifferentiation of corneal fibroblasts. Invest Ophthalmol Vis Sci (2002) 0.92
Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies. Neuroimage (2004) 0.92
Targeted deletion of the tybe IIb Na(+)-dependent Pi-co-transporter, NaPi-IIb, results in early embryonic lethality. Biochem Biophys Res Commun (2009) 0.92
Comparison between motor evoked potential recording and fiber tracking for estimating pyramidal tracts near brain tumors. J Neurosurg (2007) 0.92
Audiometry with nasally presented masking noise: novel diagnostic method for patulous eustachian tube. Otol Neurotol (2006) 0.92
FGF-4 regulates neural progenitor cell proliferation and neuronal differentiation. FASEB J (2006) 0.91
A comparative analysis of the transcriptome and signal pathways in hepatic differentiation of human adipose mesenchymal stem cells. FEBS J (2008) 0.91
A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers. Clin Cancer Res (2006) 0.91
A new model mouse for Duchenne muscular dystrophy produced by 2.4 Mb deletion of dystrophin gene using Cre-loxP recombination system. Biochem Biophys Res Commun (2005) 0.91
Brain atrophy and trunk stability during dual-task walking among older adults. J Gerontol A Biol Sci Med Sci (2011) 0.91
Self-organized calcium carbonate with regular surface-relief structures. Angew Chem Int Ed Engl (2003) 0.91
Isolation, characterization and bioactivity of a region-specific pheromone, [Val8]sodefrin from the newt Cynops pyrrhogaster. Peptides (2006) 0.90
Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjögren's syndrome. Mod Rheumatol (2009) 0.90
Induction of thermotropic bicontinuous cubic phases in liquid-crystalline ammonium and phosphonium salts. J Am Chem Soc (2012) 0.90
Stimuli-responsive luminescent liquid crystals: change of photoluminescent colors triggered by a shear-induced phase transition. Angew Chem Int Ed Engl (2008) 0.90
Pedicle versus free frozen autograft for reconstruction in malignant bone and soft tissue tumors of the lower extremities. J Orthop Sci (2013) 0.90
Video-assisted thoracoscopic surgery: hepatectomy for liver neoplasm. World J Surg (2011) 0.90
Intractable skin necrosis and interstitial pneumonia in amyopathic dermatomyositis, successfully treated with cyclosporin A. Intern Med (2003) 0.89
Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer. Cancer Sci (2012) 0.89
Crystallization of the functional domain of human thrombopoietin using an antigen-binding fragment derived from neutralizing monoclonal antibody. Acta Crystallogr D Biol Crystallogr (2002) 0.89
Rat-PET study without anesthesia: anesthetics modify the dopamine D1 receptor binding in rat brain. Synapse (2004) 0.89
Hepatocyte growth factor in saliva: a possible marker for periodontal disease status. J Oral Sci (2002) 0.89
Immune responses to DNA mismatch repair enzymes hMSH2 and hPMS1 in patients with pancreatic cancer, dermatomyositis and polymyositis. Int J Cancer (2005) 0.88
Association of p16(INK4a) and pRb inactivation with immortalization of human cells. Carcinogenesis (2002) 0.88
Three-dimensional computed tomography imaging in the sitting position for the diagnosis of patulous eustachian tube. Otol Neurotol (2007) 0.88